Perrigo Guides FY24 Well Below Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) initiated its adjusted earnings, revenue and organic net sales growth guidance for the full-year 2024.
For fiscal 2024, the company now projects adjusted earnings in a range of $2.50 to $2.65 per share on flat net sales, with organic net sales growth of 1 to 3 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.99 per share on revenue growth of 4.7 percent to $4.89 billion for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula
Perrigo Co. plc is recalling select Premium Infant Formula with Iron Milk-Based Powder sold under CVS Health and H-E-B Baby brands at the retailer and warehouse level citing elevated Vitamin D levels than permitted, according to the U.S. Food and Drug Administration. The recall involves three lots within one batch, or 16,500 cans, of store brand Premium Infant Formula with Iron Milk-Based Powder.
RTTNews
|
771 days ago
Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update
While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) said it is launching Project Energize - a global investment and efficiency program to drive the next evolution of capabilities and organizational agility.
RTTNews
|
935 days ago
Perrigo Appoints Patrick Lockwood-Taylor As President And CEO
Pharma company Perrigo Company plc (PRGO) announced Thursday the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
RTTNews
|
1199 days ago
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
Consumer Self-Care Products firm Perrigo Co. plc (PRGO) announced Monday that its company HRA Pharma has submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the U.S.
RTTNews
|
1531 days ago
U.S. Dollar Slips As Focus Shifts To Upcoming Trump's Meet With GCC Leaders
The U.S. Dollar value ticked lower on Friday after U.S. President Donald Trump hinted at returning to a possible military confrontation with Iran. Trump is planning to take a call after his upcoming meeting with the leaders of the Gulf Cooperation Council on Tuesday in New York.
RTTNews
|
23h 8min ago
Canadian Stocks Turning In Mixed Performance In Cautious Trade
Canadian stocks are turning in a mixed performance on Friday with investors largely making cautious moves, assessing geopolitical situation and weighing recent policy moves and inflation outlook from major central banks.
RTTNews
|
1 day ago
Swiss Market Ends On Weak Note
The Switzerland stock market closed notably lower on Friday, in line with markets across Europe as worries about inflation and uncertainty about central banks' monetary policy moves rendered the mood cautious.
RTTNews
|
1 day ago
European Stocks Fall As Central Bank Signals Weigh On Sentiment
European stocks declined Friday amid caution over monetary policy and inflation outlooks from major central banks. The ECB survey showed Euro Zone inflation expectations rose to 3% from 2.9%, while the Bank of Japan raised rates by 25 basis points.
RTTNews
|
1 day ago
